Demant A/S revised earnings guidance for the full year 2022. For the period, the company expects EBIT to be in the range of DKK 3.5 billion to DKK 3.8 billion compared to previous guidance of DKK 3.6 billion to DKK 3.9 billion. The company's organic revenue growth is lower to 4% to 6% from previously 5% to 9%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
326.6 DKK | +3.29% | +3.49% | +10.34% |
Apr. 08 | Denmark's Demant Finalizes Capital Reduction | MT |
Apr. 04 | Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.34% | 9.89B | |
+1.84% | 23.32B | |
+7.40% | 13.63B | |
-17.75% | 2B | |
+6.38% | 1.79B | |
+41.47% | 1.64B | |
+13.26% | 600M | |
0.00% | 475M | |
+29.63% | 134M | |
+21.80% | 86.89M |
- Stock Market
- Equities
- DEMANT Stock
- News Demant A/S
- Demant A/S Revises Earnings Guidance for the Full Year 2022